Virtual Medicinal Product (VMP) - Brodalumab 210mg/1.5ml solution for injection pre-filled syringes
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Brodalumab 210mg/1.5ml solution for injection pre-filled syringes | Start Date 24-07-2017 | End Date |
Abbreviated Name | Abbreviated Name Brodalumab 210mg/1.5ml inj pre-filled syringes | Start Date 24-07-2017 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.5
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L04AC12
- BNF Codes
-
- BNF code 13050300
Code | Start Date | End Date |
---|---|---|
34682511000001107 | 24-07-2017 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Brodalumab | Based on Ingredient Substance | 140 mg | 1 ml |
Name
Brodalumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
140.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMBrodalumab
-
VMP(Current) Brodalumab 210mg/1.5ml solution for ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
2 pre-filled disposable injection |